Pharmafile Logo

Portcullis Public Affairs

Portcullis Public Affairs is a leading government and communications consultancy, with over 25 years experience offering advice to prominent companies, charities and other organisations in the UK. Health specialisms include public affairs, government relations in the UK and Europe, and crisis management. We help Government reach better decisions. Portcullis is in partnership with MAP BioPharma which helps clients navigate the detailed processes so as to achieve optimal market access in the UK, Ireland and Germany. Together, we provide a unique combination of public affairs capabilities and detailed market analyses.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

11 Haymarket, London, SW1Y 4BP, United Kingdom
+44 (0)20 7368 3100

 Latest Content from PMHub 

Supporting Blood Cancer Patients: The Importance of Patient-Centric Pharma Campaigns

White Papers and Resources | September 27, 2024 | Mednet

This Blood Cancer Awareness Month, we want to highlight the critical role of patient-centricity in building awareness, understanding, and support for those living with blood cancers.

Advantages of Virtual Collaboration – Perks of Virtual Medical Education

Videos and Podcasts | September 26, 2024 | Impetus Digital

From extended reach and enhanced interactivity to increased speed and flexibility, learn why virtual settings are becoming a staple in education and professional interaction. Embrace the future of collaboration today!

Driving behaviour change for positive patient outcomes in pharma

Press Releases | September 25, 2024 | Graphite Digital

Discover how pharma can help to achieve better patient health outcomes by informing patient behaviour through insights, strategy and collaboration.

How Design Systems enable streamlined regulatory approval in digital pharma

Press Releases | September 25, 2024 | Graphite Digital

The strict compliance guidelines that exist within pharma can mean that digital content and platforms can take a long time to be approved and involve lots of back and forth...

What is willingness to pay? – Comparing price testing methodologies

Heather Wellam (Senior Consultant – Market Access, Mtech Access) explores the concept of willingness to pay (WTP) and what it means for pharmaceutical and medtech pricing strategy. Read on to...

Unlock the Future of Medical Publications—Next Week!

Press Releases | September 19, 2024 | Impetus Digital

Dive into a comprehensive exploration of the latest trends and cutting-edge strategies in medical publication planning. Our exclusive webinar series, starting next week, offers a deep dive into the intricacies...

Innovative Trials’ CEO wins Women in Pharma Award

Press Releases | September 19, 2024 | Innovative Trials

Kate Shaw, founder and CEO of Innovative Trials, a global clinical trial patient recruitment and retention company, won the ‘Woman in Pharma’ at the Pharma Industry Awards UK. She was...

Where did “KOLs” come from, and why do they matter?

White Papers and Resources | September 19, 2024 | Mednet

Ever wondered where 'KOLs' came from and why they matter? Dr Alex Loveday answers those questions in this latest edition of her column.